External
LabMed is hosting the LabMed Leaders Summit as part of The IBMS Congress (22-25 September 2025). This is an essential strategic meeting for senior laboratory staff and managers, across all pathology disciplines.
LabMed Members can book the event at IBMS member rates to attend both the Congress as a whole and/or the Laboratory Medicine Leaders Summit.
To get the member discount, you must use our unique discount link - https://ibmscongress25.eventreference.com/labmed. To get an additional earlybird discount, book your tickets before 30 June.
Programme
9am
Welcome from the LabMed President
Ian Godber, LabMed President, Consultant Clinical Scientist, QEUH, NHS Greater Glasgow & Clyde
Abstract
A warm welcome to the second Laboratory Medicine Leaders’ Summit developed by the Association for Laboratory Medicine and hosted at the IBMS Congress.
The introduction to the meeting will overview the current challenges that senior laboratory staff and managers face and highlight new developments in laboratory medicine which will be covered throughout the day.
9.10am
Delivering great organisational leadership
Dennis Dunn MBE, Former Chair of Mid Cheshire Hospitals Foundation Trust
9.35am
Digital readiness: responding to the unexpected
Karen Mitchell, NHS Grampian
10.30am
The missing link in the governance process
Finlay McKenzie, UK NEQAS, Birmingham
11am
Value-added EQA can check clinical appropriateness in the use of assays
Rachel Marrington, Consultant EQA Scientist & Deputy Director, Birmingham Quality (UK NEQAS)
Naomi Elkin, UK NEQAS, Glasgow
11.30am
The role of laboratory EQA in patient safety
Gwen Wark, Berkshire & Surrey Pathology Services
2pm
AI: What can we learn from its application in cancer research
Harriet Unsworth, Cancer Research UK, University of Manchester
Abstract
Artificial intelligence has been heralded as a having the potential to transform healthcare, from drug and biomarker discovery to improved diagnostics and AI decision support tools to improve therapeutic strategies. However, adoption of AI in the NHS is patchy and value can be hard to measure. In this presentation I’ll share my experiences from digital and AI cancer research, and national initiatives to standardise AI for healthcare.
I’ll talk through the potential patient and system impacts of AI transformation in cancer research and cancer care – the good, the bad and the ugly. I’ll use examples from my team’s research and the broader health and care system, to describe ongoing challenges in AI transformation, including data access, NHS IT infrastructure and working in interdisciplinary teams. I’ll also describe some of the new approaches that are being developed to ensure that healthcare AI is transparent and fair for everyone.
I’ll talk through the potential patient and system impacts of AI transformation in cancer research and cancer care – the good, the bad and the ugly. I’ll use examples from my team’s research and the broader health and care system, to describe ongoing challenges in AI transformation, including data access, NHS IT infrastructure and working in interdisciplinary teams. I’ll also describe some of the new approaches that are being developed to ensure that healthcare AI is transparent and fair for everyone.
2.30pm
Algorithmic bias and health inequity: addressing risks in medical artificial intelligence
Joseph Alderman, Clinical Research Fellow, Anaesthesia and Critical Care Doctor, University of Birmingham
Abstract
Health data is highly complex and can be challenging to interpret without knowing the context in which it was created. Data biases can be encoded into artificial intelligence (AI) health technologies, worsening existing health inequalities at scale. The STANDING Together recommendations give guidance to those who are creating and using health data on how to minimise this risk. They were developed via an international consensus process involving representatives from 58 countries. In this session, one of the lead researchers for STANDING Together will talk through the recommendations and how they can help ensure AI health technologies are safe and effective for everyone.
3pm
Project PathLAKE: selecting the right patients for the best therapy
David Snead, University Hospitals of Coventry and Warwickshire
4pm
Diagnostic stewardship: a lever to lower carbon?
Rob Shorten, Consultant Clinical Scientist, Lancashire Teaching Hospitals
4.30pm
Inappropriate testing: the cost to the planet
Tim Lang, Newcastle upon Tyne Hospitals
Ticket prices
The prices below are at LabMed/ IBMS member rates.
Find out more by visiting the IBMS Congress website.